PHAT
Price
$8.92
Change
+$0.01 (+0.11%)
Updated
Jul 3 closing price
Capitalization
622.74M
33 days until earnings call
RGNX
Price
$8.74
Change
+$0.12 (+1.39%)
Updated
Jul 3 closing price
Capitalization
440.4M
25 days until earnings call
Interact to see
Advertisement

PHAT vs RGNX

Header iconPHAT vs RGNX Comparison
Open Charts PHAT vs RGNXBanner chart's image
Phathom Pharmaceuticals
Price$8.92
Change+$0.01 (+0.11%)
Volume$499.12K
Capitalization622.74M
REGENXBIO
Price$8.74
Change+$0.12 (+1.39%)
Volume$423.94K
Capitalization440.4M
PHAT vs RGNX Comparison Chart in %
Loading...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHAT vs. RGNX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAT is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (PHAT: $8.92 vs. RGNX: $8.74)
Brand notoriety: PHAT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHAT: 15% vs. RGNX: 38%
Market capitalization -- PHAT: $622.74M vs. RGNX: $440.4M
PHAT [@Biotechnology] is valued at $622.74M. RGNX’s [@Biotechnology] market capitalization is $440.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAT’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • PHAT’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAT’s TA Score shows that 5 TA indicator(s) are bullish while RGNX’s TA Score has 3 bullish TA indicator(s).

  • PHAT’s TA Score: 5 bullish, 5 bearish.
  • RGNX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than RGNX.

Price Growth

PHAT (@Biotechnology) experienced а -6.60% price change this week, while RGNX (@Biotechnology) price change was -0.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

PHAT is expected to report earnings on Aug 07, 2025.

RGNX is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($623M) has a higher market cap than RGNX($440M). RGNX YTD gains are higher at: 13.066 vs. PHAT (9.852). RGNX has higher annual earnings (EBITDA): -122.44M vs. PHAT (-272.12M). RGNX has more cash in the bank: 268M vs. PHAT (212M). RGNX has less debt than PHAT: RGNX (79.8M) vs PHAT (204M). RGNX has higher revenues than PHAT: RGNX (157M) vs PHAT (81.9M).
PHATRGNXPHAT / RGNX
Capitalization623M440M142%
EBITDA-272.12M-122.44M222%
Gain YTD9.85213.06675%
P/E RatioN/AN/A-
Revenue81.9M157M52%
Total Cash212M268M79%
Total Debt204M79.8M256%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
23
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHATRGNX
RSI
ODDS (%)
Bearish Trend 3 days ago
68%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCPIX51.330.43
+0.84%
DWS S&P 500 Index S
DAABX20.070.12
+0.60%
DFA US Sustainability Targeted Val Instl
ELMCX18.090.07
+0.39%
Lord Abbett Emerging Markets Equity C
PMFKX13.060.04
+0.31%
Victory Pioneer Multi-Asset Income R6
PGUCX15.620.02
+0.13%
Virtus Duff & Phelps Global Infras C

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TNFA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
+0.11%
TNFA - PHAT
39%
Loosely correlated
+2.07%
ATRA - PHAT
36%
Loosely correlated
+2.61%
URGN - PHAT
36%
Loosely correlated
+4.78%
RGNX - PHAT
35%
Loosely correlated
+1.39%
PDSB - PHAT
35%
Loosely correlated
+4.72%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with DNLI. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
+1.39%
DNLI - RGNX
55%
Loosely correlated
-1.41%
BEAM - RGNX
54%
Loosely correlated
+0.65%
ARWR - RGNX
54%
Loosely correlated
-0.65%
VYGR - RGNX
52%
Loosely correlated
N/A
ALEC - RGNX
51%
Loosely correlated
+0.67%
More